IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Advertisement
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Evonik introduces new technology focus to nutrition strategy

Evonik Industries has recently made some significant moves to add to its animal nutrition business and build its capabilities in supporting on-farm monitoring. Animal Pharm editor Joseph Harvey spoke to the firm about why it is making a play in this burgeoning space.

Poultry R&D

Phibro predicts 2-4% future growth for antibiotics portfolio

Phibro believes its antibiotics business will continue to grow by 2-4% annually, while sales shift over to more therapeutic use.

Phibro Animal Health Operations

Evonik: Strong science can be differentiator in next-generation animal nutrition

In recent years, Evonik Industries has increased its presence in the area of animal probiotics. The company believes good science can set it aside from its competitors in a global market becoming more attuned to animal welfare and food safety. Animal Pharm editor Joseph Harvey met a team of experts from the firm at its headquarters in Germany to find out more.

Food Animals Feed & Additives

Elanco will stick to its core competency as a product-focused company

Elanco's recent spending spree has built on its expertise as a late-stage developer of new products, according to Jeff Simmons.

Elanco M&A

Animalcare: 'We're building the pipeline and not the footprint'

Jenny Winter took over the reins of UK firm Animalcare around 10 months ago, bringing expertise from the human healthcare space. Animal Pharm editor Joseph Harvey met the chief executive in London to discuss the firm's strategy, its aspirations for growth and her initial thoughts on the wider animal health sector.

Operations Markets

Inalve hopes investment will support microalgae fishmeal business

French firm Inalve aims to secure investment and begin commercializing its alternative fish feed in 2020.

Aquaculture Feed & Additives
See All
Advertisement
UsernamePublicRestriction

Register